Clinical and Translational Medicine (Nov 2024)

Myelofibrosis predicts deep molecular response 4.5 in chronic myeloid leukaemia patients initially treated with imatinib: An extensive, multicenter and retrospective study to develop a prognostic model

  • Tian Zeng,
  • Xiudi Yang,
  • Yi Wang,
  • Dijiong Wu,
  • Weiying Feng,
  • Ying Lu,
  • Xiaoqiong Zhu,
  • Lirong Liu,
  • Mei Zhou,
  • Li Zhang,
  • Yanping Shao,
  • Honglan Qian,
  • Feng Zhu,
  • Yu Chen,
  • Dan Cao,
  • Li Huang,
  • Xiaoning Feng,
  • Lili Chen,
  • Gang Zhang,
  • Jing Le,
  • Weiguo Zhu,
  • Yongming Xia,
  • Yanxia Han,
  • Yongqing Jia,
  • Guoyan Tian,
  • Hui Zhou,
  • Linjuan Xu,
  • Xiufeng Yin,
  • Qinli Tang,
  • Yuefeng Zhang,
  • Guoli Yao,
  • Xianghua Lang,
  • Kaifeng Zhang,
  • Xiujie Zhou,
  • Junbin Guo,
  • Jinming Tu,
  • Jianzhi Zhao,
  • Gongqiang Wu,
  • Huiqi Zhang,
  • Xiao Wu,
  • Qiulian Luo,
  • Lihong Cao,
  • Binbin Chu,
  • Wei Jiang,
  • Haiying Wu,
  • Liansheng Huang,
  • Meiwei Hu,
  • Muqing He,
  • Jingjing Zhu,
  • Hongyan Tong,
  • Jie Jin,
  • Jian Huang

DOI
https://doi.org/10.1002/ctm2.70101
Journal volume & issue
Vol. 14, no. 11
pp. n/a – n/a

Abstract

Read online

No abstracts available.